ArticleMedical mycology case reports2026
Invasive pulmonary aspergillosis following mild Covid-19 in an autologous hematopoietic stem cell transplant recipient: A case report.
Article in Medical mycology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19-associated pulmonary aspergillosis (CAPA) is typically described in critically ill patients with severe pneumonia. We report a 68-year-old man, 16 weeks post autologous hematopoietic stem cell transplant for AL amyloidosis, who developed invasive pulmonary aspergillosis (IPA) following mild COVID-19 upper respiratory tract infection not requiring oxygen supplementation or ICU admission. Diagnosis was established by positive broncho-alveolar lavage galactomannan with compatible CT chest findings, and he was treated with oral voriconazole. This case highlights that IPA may complicate mild COVID-19 in patients not traditionally considered at highest risk, supporting the concept that cumulative risk factors may precipitate IPA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.